FORM 8-K

Company

Lexaria Bioscience Corp.

Filed

January 28, 2026

Period of Report

January 27, 2026

Accession Number

0001640334-26-000162

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →